Paradigm - About the company
Paradigm is a series A company based in New York City (United States), founded in 2003 by Milind Kamkolkar. It operates as a Provider of clinical research healthcare services. Paradigm has raised $203M in funding from General Catalyst and Arch Venture Partners. The company has 164 active competitors, including 44 funded and 16 that have exited. Its top competitors include companies like Evidation, myTomorrows and SubjectWell.
Key Metrics
Founded Year
2003
Location
New York City, United States
Stage
Series A
Total Funding
$203M in 1 round
Latest Funding Round
Investors
Ranked
7th among 164 active competitors
Employee Count
198 as on Mar 31, 2026
Investment & Acquisitions
Sign up to download Paradigm's company profile
Paradigm's funding and investors
Paradigm has raised a total funding of $203M over 1 round. Its latest funding round was a Series A round on Jan 25, 2023 for $*****. 8 investors participated in its latest round. Paradigm has 8 institutional investors.
Here is the list of recent funding rounds of Paradigm:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 25, 2023 | 9114987 | Series A | 7521712 | 4153405 | 9753169 | 2523682 |
View details of Paradigm's funding rounds and investors
Paradigm's founders and board of directors
Founder? Claim ProfileThe founders of Paradigm is Milind Kamkolkar.
Here are the details of Paradigm's key team members:
- Milind Kamkolkar: Co-Founder, Former COO & Strategic Advisor of Paradigm.
View details of Paradigm's Founder profiles and Board Members
Paradigm's employee count trend
Paradigm has 198 employees as of Mar 26. Here is Paradigm's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Paradigm's Competitors and alternates
Top competitors of Paradigm include Evidation, myTomorrows and SubjectWell. Here is the list of Top 10 competitors of Paradigm, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Evidation 2012, Menlo Park (United States), Series E | Real-world health data insights for better healthcare decisions and research | $259M | 75/100 | |
2nd | myTomorrows 2012, Amsterdam (Netherlands), Series C | Platform provides access to drugs in development to patients and physicians | $51.3M | 67/100 | |
3rd | SubjectWell 2012, Austin (United States), Acquired | Provider of clinical trials marketplace offering solutions for patient recruitment | $46.8M | 60/100 | |
4th | Cloud based clinical trial recruitment solutions for pharmaceutical companies, analytics, services | $27.1M | 59/100 | ||
5th | Dyania Health 2019, Sacramento (United States), Series A | Developer of an AI platform for healthcare data extraction and analysis | $15.3M | 59/100 | |
6th | Circuit Clinical 2014, Buffalo (United States), Series C | Research site network platform focuses on patient identification, enrollment, recruitment & retention | $47.7M | 58/100 | |
7th | Paradigm 2003, New York City (United States), Series A | Provider of clinical research healthcare services | $203M | 55/100 | |
8th | Little Journey 2018, London (United Kingdom), Series A | Provider of digital health solutions for pediatric healthcare | $13.2M | 55/100 | |
9th | BEKHealth 2016, New York City (United States), Series C | Provider of patient screening, recruitment, and analytics solution | $15.7M | 55/100 | |
10th | Antidote 2008, London (United Kingdom), Series C | Provider of search engine tool for patients to explore, understand and access clinical trials. | $52M | 55/100 |
Looking for more details on Paradigm's competitors? Click here to see the top ones
Paradigm's Investments and acquisitions
Paradigm has acquired Deep Lens. Paradigm has not made any investments as of now.Reports related to Paradigm
Here is the latest report on Paradigm's sector:
News related to Paradigm
Media has covered Paradigm for a total of 3 events in the last 1 year, 2 of them have been about partnerships and 1 about company updates.
•
Parexel and Paradigm Health Partner to Expand Access and Efficiency in Clinical TrialsGlobeNewswire•Sep 16, 2025•Paradigm, Parexel
•
Cressey & Company Partners with Paradigm HealthGlobal Legal Chronicle•Jun 03, 2025•Paradigm, Cressey & Company
•
•
Japan’s National Cancer Center Selects Paradigm for Nationwide Clinical Trial NetworkHIT Consultant•Nov 07, 2024•Precision Medicine, Paradigm
•
Sheba Medical, Paradigm Health Partner to Optimize Clinical TrialsHIT Consultant•Sep 12, 2024•Sheba Medical Center, Paradigm
•
FCS Partners with Paradigm to Expand Clinical Trial AccessHIT Consultant•Sep 03, 2024•Florida Cancer Specialists, Paradigm
•
Fujitsu Partners With Paradigm For Enhanced Clinical TrialsHIT Consultant•Aug 26, 2024•Fujitsu, Paradigm
•
Paradigm Leads $70 Million Funding Round for Babylon Bitcoin ProjectFinancial Post•May 30, 2024•BabylonChain, Paradigm, Polychain, Bullish and 12 others
•
Paradigm and Altru Health System Expand Patient Access to Clinical Trials for Rural PopulationPR Newswire•May 29, 2024•Paradigm, Altru
•
BMS taps Arch-backed startup to change cancer trial Paradigm, accelerate enrollmentFierce Biotech•Oct 06, 2023•Paradigm, Bristol-Myers Squibb
Are you a Founder ?
FAQs about Paradigm
Explore our recently published companies
- Urban Den - Jodhpur based, 2020 founded, Unfunded company
- Arab GT - Dubai based, 2009 founded, Unfunded company
- Crystalline Software Technologies - Hyderabad based, 2009 founded, Unfunded company
- Lakson Technology - Chennai based, 2006 founded, Unfunded company
- Tikino - Paris based, 2019 founded, Funding Raised company
- Bismarck World - Mumbai based, 2021 founded, Unfunded company
